Skip to main content
Premium Trial:

Request an Annual Quote

Orchid Delays Release of 2004 10-K Due to December Departure of CFO Spicer

NEW YORK, March 18 (GenomeWeb News) - Orchid Biosciences has delayed the release of its 10-K 2004 earnings report due to the recent departure of CFO Mike Spicer, and because the SEC now considers Orchid to be an accelerated filer, the company said in a document filed with the SEC yesterday.

 

The company issued a press release reporting its fourth-quarter and year-end 2004 earnings earlier this month. The company said it will file the form by March 31.

In today's SEC filing, Orchid said the delay occured because 2005 is "the first year that the Registrant is an accelerated filer for purposes of filing its periodic reports and the Resitrant's  Chief Financial Officer, whio is charged with the primary responsibility for preparing the Form 10-K and its supporting schedules, resigned effective as of December 31, 2004."

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.